EVERSANA has acquired Waltz Health for an undisclosed amount. This strategic purchase integrates Waltz Health, a company focused on transforming prescription care, into EVERSANA's portfolio. Waltz Health is known for leading a new way forward in the pharmaceutical supply chain by addressing high costs and broken experiences. The company develops AI-driven marketplaces designed to reduce costs and introduces new consumer tools to guide decisions on care, catering to payers, pharmacies, and individual consumers. This move represents a corporate acquisition, where EVERSANA has bought Waltz Health outright.
Waltz Health's solutions center on creating a smarter pharmaceutical marketplace, rewiring how the system works through better pricing, increased information, and intelligent tools. Its offerings include a multi-card search marketplace solution, enabling consumers to find the best prescription prices at their preferred pharmacies. EVERSANA’s acquisition of Waltz Health is poised to enhance its capabilities within the life sciences sector, leveraging Waltz’s innovative approach to improve transparency and efficiency in prescription management.
The integration of Waltz Health’s AI-powered technology and consumer-centric tools is expected to create significant synergies. These will allow EVERSANA to deliver more comprehensive solutions that aim to lower pharmaceutical costs, streamline patient access to medication, and empower consumers with better information. The combined entity will focus on improving the overall prescription experience, making it more transparent and affordable for all stakeholders, from payers to individual patients.
This acquisition underscores a commitment to driving innovation within the complex pharmaceutical supply chain. The combined efforts of EVERSANA and Waltz Health are set to accelerate the development of advanced solutions that address critical challenges in prescription care, ultimately working towards better outcomes and a more accessible healthcare system for consumers.